Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cytokinetics raises $20mm in Series B preferred offering

Executive Summary

Cellular bioinformatics start-up Cytokinetics raised $20mm in a Series B preferred stock private placement.through new investors International Biomedicine Holdings, Vulcan Ventures (both of which led the round), Duke University, and New Medical Technologies, joined by returning participants Mayfield Fund and Sevin Rosen Funds.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies